Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Omnicell

IBD Rating Upgrades: Omnicell Shows Improved Technical Strength

A Relative Strength Rating upgrade for Omnicell shows improving technical performance. Will it continue?

Investors Business Daily

Stocks Showing Market Leadership: Omnicell Earns 97 RS Rating

Stocks Showing Market Leadership: Omnicell Earns 97 RS Rating

Omnicell shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Omnicell Catapults And Breaks Out After Obliterating Profit Expectations

Omnicell Catapults And Breaks Out After Obliterating Profit Expectations

Omnicell stock broke out Wednesday after the medications management company obliterated its own earnings expectations.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital’s computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

Tribune News Service

inkl

Read news from The Economist, FT, and more,
with one subscription

Omnicell's Q4 Earnings In Line With Expectations, Issues Mixed FY22 Guidance

Omnicell's Q4 Earnings In Line With Expectations, Issues Mixed FY22 Guidance

Omnicell Inc's (NASDAQ: OMCL)

Recap: Omnicell Q4 Earnings

Recap: Omnicell Q4 Earnings

Omnicell (NASDAQ:OMCL) reported its Q4 earnings results on Monday, February 14, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Omnicell reported in-line EPS of $0.92 versus an estimate of $0.92.

Preview: Omnicell's Earnings

Preview: Omnicell's Earnings

Omnicell (NASDAQ:OMCL) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Omnicell will likely report an Earnings Per Share (EPS) of $0.92.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Delta Air Lines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

261,135 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play